Latest Trials

Systemic therapy trial

A Phase 1 Pharmacokinetic and Pharmacodynamic Study of TG-1701, an Irreversible Bruton's...

This phase I trial is evaluating the safety and effectiveness of a new oral drug (TG-1701) for patients with B-cell malignancies that have not responded or gotten worse with prior treatments

Status : Recruiting

Systemic therapy trial

A Phase 1/2 Study to Evaluate Safety, Pharmacokinetics and Efficacy of Isatuximab in...

This phase I/II trial is evaluating a combination of two intravenous drugs (Isatuximab and Cemiplimab) for patients with multiple myeloma that has gotten worse or not responded to prior treatment

Status : Recruiting

Systemic therapy trial

D6070C00005 : A Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of...

This phase I/II trial is evaluating two immunotherapy drugs (MEDI9447 and durvalumab) given alone or in combination, with chemotherapy, in patients with pancreatic cancer that has spread to other parts of the body

Status : Recruiting

Systemic therapy trial

ALLG APML5 : A phase I pharmacokinetic evaluation of oral arsenic trioxide in previously untreated...

This phase I trial is evaluating an oral anti-cancer drug (arsenic trioxide) as a consolidation therapy for acute promyelocytic leukaemia (APML)

Status : Recruiting

Systemic therapy trial

BGB-290-103 : A Phase 1b Study to Assess the Safety, Tolerability and Clinical Activity of BGB-290 in...

This phase I/II trial is evaluating a new drug (BGB-290) in combination with an oral chemotherapy drug (Temozolomide) in patients with locally advanced or metastatic solid cancers

Status : Recruiting

Systemic therapy trial

UTX-TGR-205 : A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of...

This phase II/III trial is evaluating the safety and effectiveness of a new oral drug (TGR-1202) in combination with a type of immunotherapy (ublituximab) with or without chemotherapy (bendamustine) in patients with recurrent or refractory Non-Hodgkin's Lymphoma

Status : Recruiting

Systemic therapy trial

An International Phase Ib Multicentre Study to Characterize the Safety and Tolerability...

This phase I trial is evaluating the combination of a new intravenous drug (S64315) and an oral chemotherapy drug (venetoclax) in patients with Acute Myeloid Leuakemia (AML)

Status : Recruiting

Systemic therapy trial

APOLLO-1 : A Phase 1/2 Dose Escalation and Expansion Study of Combination CBT-501 or Nivolumab With...

This phase I/II trial is evaluating the combination of an oral drug (CBT-101) with two immunotherapy drugs (CBT-501 or Nivolumab) in patients with locally advanced or metastatic hepatocellular cancer (liver cancer) or renal cell carcinoma (a type of kidney cancer)

Status : Recruiting

Systemic therapy trial

A Phase 1b/2 Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in...

This phase I/II trial is evaluating the safety and effectiveness of an oral drug (BMS-813160) alone or in combination with immunotherapy (Nivolumab) and/or chemotherapy in patients with advanced solid cancers, particularly colorectal cancer or pancreatic cancer

Status : Recruiting

Systemic therapy trial

PEGASUS : A Phase III, Randomized, Multi-Center, Open-Label, Active-Comparator Controlled Study to...

This phase III trial is comparing two drugs (APL-2 and Eculizumab) for the treatment of the rare blood disease Paroxysmal Nocturnal Hemoglobinuria (PNH)

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.